BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, highlighted the presentation of the two-year results for the SENTRY trial, at the Vascular Interventional Advances ...

LAS VEGAS — Use of a bioconvertible inferior vena cava filter successfully prevented new-onset pulmonary embolism in high-risk patients and was bioresorbed within 1 year in most cases, according to ...

BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, today announced the first patients outside of a clinical trial have been successfully implanted with the BTG Sentry ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. LAS VEGAS — Use of a bioconvertible inferior vena cava ...

If you have had a deep vein thrombosis (DVT), you may worry about having another life-threatening clot. People who’ve had a DVT and can’t take blood-thinning medications have another option to prevent ...

The Inferior Vena Cava (IVC) filter is a crucial medical device designed to prevent the occurrence of a pulmonary embolism (PE), a condition that can be fatal if untreated. The Inferior Vena Cava (IVC ...

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the Global Inferior Vena Cava (IVC) Filter Market 2025-2035," provides a ...

in reducing potential complications seen with conventional filters.